SCHEMBL14728110

SCHEMBL14728110

CCn1c2ccccc2c2cc3c4ccc(-c5ccc(-c6ccccc6)cn5)cc4c4ccccc4c3cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 6/20 0.47
RAC2 P15153 1/20 0.45
RAC3 P60763 1/20 0.45
CDC42 P60953 1/20 0.45
RAC1 P63000 1/20 0.45
PTGES O14684 1/20 0.44
METAP2 P50579 1/20 0.43
KDM1A O60341 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
HBB P68871 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TSPO P30536 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14728105 0.86 NPY5R (0.53) NPY5RRAC2RAC3CDC42RAC1
SCHEMBL14716350 0.86 TSPO (0.52) NPY5RRAC2RAC3CDC42RAC1
SCHEMBL14728077 0.86 TSPO (0.52) NPY5RRAC2RAC3CDC42RAC1
SCHEMBL14728079 0.84 NPY5R (0.50) NPY5RRAC2RAC3CDC42RAC1
SCHEMBL14728080 0.84 NPY5R (0.50) NPY5RRAC2RAC3CDC42RAC1
SCHEMBL14728083 0.82 NPY5R (0.51) NPY5RRAC2RAC3CDC42RAC1
SCHEMBL14728101 0.81 NPY5R (0.49) NPY5RRAC2RAC3CDC42RAC1
SCHEMBL14728162 0.81 L3MBTL1 (0.44) KDM4EMEN1ALDH1A1MAPTHTT
SCHEMBL14728085 0.81 NPY5R (0.51) NPY5RRAC2RAC3CDC42RAC1
SCHEMBL14728104 0.81 NPY5R (0.53) NPY5RRAC2RAC3CDC42RAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9017829-B2 Phenanthrocarbazole compound, and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2015-04-28 US disclosed
US-9017829-B2 Phenanthrocarbazole compound, and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2015-04-28 US disclosed
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2013-02-28 US disclosed
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME PPOX, ORC3, CACNA2D3 NPY5R 4298/4885RAC2 4188/4885RAC3 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.